{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T14:52:10Z","timestamp":1791989530112,"version":"4.4.0"},"reference-count":60,"publisher":"Spandidos Publications","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,10]]},"DOI":"10.3892\/or.2014.3379","type":"journal-article","created":{"date-parts":[[2014,8,4]],"date-time":"2014-08-04T09:43:11Z","timestamp":1407145391000},"page":"1347-1354","source":"Crossref","is-referenced-by-count":15,"title":["TAGLN expression is upregulated in NF1-associated malignant peripheral nerve sheath tumors by hypomethylation in its promoter and subpromoter regions"],"prefix":"10.3892","volume":"32","author":[{"given":"GUN-HOO","family":"PARK","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"SU-JIN","family":"LEE","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"HYUNE","family":"YIM","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"JAE-HO","family":"HAN","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"HYON J.","family":"KIM","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"YOUNG-BAE","family":"SOHN","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"JUNG MIN","family":"KO","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"SEON-YONG","family":"JEONG","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2249","published-online":{"date-parts":[[2014,8,4]]},"reference":[{"key":"key20180107205826_b1-or-32-04-1347","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jaad.2008.12.051","article-title":"Neurofibromatosis type 1","volume":"61","author":"Boyd","year":"2009","journal-title":"J Am Acad Dermatol"},{"key":"key20180107205826_b2-or-32-04-1347","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1146\/annurev.pathol.2.010506.091940","article-title":"Neurofibromatosis","volume":"2","author":"McClatchey","year":"2007","journal-title":"Annu Rev Pathol"},{"key":"key20180107205826_b3-or-32-04-1347","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/0092-8674(90)90253-B","article-title":"A major segment of the neurofibromatosis type 1 gene: cDNA sequence, genomic structure, and point mutations","volume":"62","author":"Cawthon","year":"1990","journal-title":"Cell"},{"key":"key20180107205826_b4-or-32-04-1347","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/GIM.0b013e3181bf15e3","article-title":"Clinical and genetic aspects of neurofibromatosis 1","volume":"12","author":"Jett","year":"2010","journal-title":"Genet Med"},{"key":"key20180107205826_b5-or-32-04-1347","doi-asserted-by":"crossref","first-page":"e30","DOI":"10.1017\/S1462399409001227","article-title":"Malignant peripheral nerve sheath tumour (MPNST): the clinical implications of cellular signalling pathways","volume":"11","author":"Katz","year":"2009","journal-title":"Expert Rev Mol Med"},{"key":"key20180107205826_b6-or-32-04-1347","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1136\/jmg.39.5.311","article-title":"Malignant peripheral nerve sheath tumours in neurofibromatosis 1","volume":"39","author":"Evans","year":"2002","journal-title":"J Med Genet"},{"key":"key20180107205826_b7-or-32-04-1347","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1002\/jso.20971","article-title":"Malignant peripheral nerve sheath tumor: molecular pathogenesis and current management considerations","volume":"97","author":"Grobmyer","year":"2008","journal-title":"J Surg Oncol"},{"key":"key20180107205826_b8-or-32-04-1347","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/S1470-2045(09)70033-6","article-title":"Mechanisms in the pathogenesis of malignant tumours in neurofibromatosis type 1","volume":"10","author":"Brems","year":"2009","journal-title":"Lancet Oncol"},{"key":"key20180107205826_b9-or-32-04-1347","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.anndiagpath.2013.10.007","article-title":"Malignant peripheral nerve sheath tumor: pathology and genetics","volume":"18","author":"Thway","year":"2014","journal-title":"Ann Diagn Pathol"},{"key":"key20180107205826_b10-or-32-04-1347","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1002\/humu.20601","article-title":"Germline and somatic NF1 gene mutation spectrum in NF1-associated malignant peripheral nerve sheath tumors (MPNSTs)","volume":"29","author":"U padhyaya","year":"2008","journal-title":"Hum Mutat"},{"key":"key20180107205826_b11-or-32-04-1347","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S0165-4608(99)00006-0","article-title":"Allelic loss of the NF1 gene in NF1-associated plexiform neurofibromas","volume":"113","author":"Kluwe","year":"1999","journal-title":"Cancer Genet Cytogenet"},{"key":"key20180107205826_b12-or-32-04-1347","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1002\/gcc.2870100405","article-title":"TP53 mutations are frequent in malignant NF1 tumors","volume":"10","author":"Legius","year":"1994","journal-title":"Genes Chromosomes Cancer"},{"key":"key20180107205826_b13-or-32-04-1347","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1016\/S0002-9440(10)65507-1","article-title":"Malignant transformation of neurofibromas in neurofibromatosis 1 is associated with CDKN2A\/p16 inactivation","volume":"155","author":"Nielsen","year":"1999","journal-title":"Am J Pathol"},{"key":"key20180107205826_b14-or-32-04-1347","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1007\/s00428-001-0550-4","article-title":"Immunohistochemical and molecular analysis of p53, RB, and PTEN in malignant peripheral nerve sheath tumors","volume":"440","author":"Mawrin","year":"2002","journal-title":"Virchows Arch"},{"key":"key20180107205826_b15-or-32-04-1347","doi-asserted-by":"crossref","first-page":"937","DOI":"10.2741\/3727","article-title":"Genetic basis of tumorigenesis in NF1 malignant peripheral nerve sheath tumors","volume":"16","author":"Upadhyaya","year":"2011","journal-title":"Front Biosci"},{"key":"key20180107205826_b16-or-32-04-1347","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1016\/j.cell.2013.01.053","article-title":"CXCR4\/CXCL12 mediate autocrine cell-cycle progression in NF1-associated malignant peripheral nerve sheath tumors","volume":"152","author":"Mo","year":"2013","journal-title":"Cell"},{"key":"key20180107205826_b17-or-32-04-1347","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1158\/1078-0432.CCR-06-0182","article-title":"Microarray-based identification of tenascin C and tenascin XB, genes possibly involved in tumorigenesis associated with neurofibromatosis type 1","volume":"13","author":"L\u00e9vy","year":"2007","journal-title":"Clin Cancer Res"},{"key":"key20180107205826_b18-or-32-04-1347","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1136\/jcp.54.8.631","article-title":"Malignant peripheral nerve sheath tumour arising within neurofibroma. An immunohistochemical analysis in the comparison between benign and malignant components","volume":"54","author":"Watanabe","year":"2001","journal-title":"J Clin Pathol"},{"key":"key20180107205826_b19-or-32-04-1347","doi-asserted-by":"crossref","first-page":"8573","DOI":"10.1073\/pnas.0503224102","article-title":"The NF1 tumor suppressor critically regulates TSC2 and mTOR","volume":"102","author":"Johannessen","year":"2005","journal-title":"Proc Natl Acad Sci USA"},{"key":"key20180107205826_b20-or-32-04-1347","doi-asserted-by":"crossref","first-page":"657","DOI":"10.3892\/ijo.2012.1751","article-title":"NF1 deficiency causes Bcl-xL upregulation in Schwann cells derived from neurofibromatosis type 1-associated malignant peripheral nerve sheath tumors","volume":"42","author":"Park","year":"2013","journal-title":"Int J Oncol"},{"key":"key20180107205826_b21-or-32-04-1347","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1002\/glia.20776","article-title":"How does the Schwann cell lineage form tumors in NF1?","volume":"56","author":"Carroll","year":"2008","journal-title":"Glia"},{"key":"key20180107205826_b22-or-32-04-1347","doi-asserted-by":"crossref","first-page":"19479","DOI":"10.1073\/pnas.0910398106","article-title":"PTEN dosage is essential for neurofibroma development and malignant transformation","volume":"106","author":"Gregorian","year":"2009","journal-title":"Proc Natl Acad Sci USA"},{"key":"key20180107205826_b23-or-32-04-1347","doi-asserted-by":"crossref","first-page":"1924","DOI":"10.1158\/1078-0432.CCR-10-1551","article-title":"Array-based comparative genomic hybridization identifies CDK4 and FOXM1 alterations as independent predictors of survival in malignant peripheral nerve sheath tumor","volume":"17","author":"Yu","year":"2011","journal-title":"Clin Cancer Res"},{"key":"key20180107205826_b24-or-32-04-1347","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1038\/modpathol.2012.242","article-title":"Expression profiling of 519 kinase genes in matched malignant peripheral nerve sheath tumor\/plexiform neurofibroma samples is discriminatory and identifies mitotic regulators BUB1B, PBK and NEK2 as overexpressed with transformation","volume":"26","author":"Stricker","year":"2013","journal-title":"Mod Pathol"},{"key":"key20180107205826_b25-or-32-04-1347","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/B978-0-12-380866-0.60002-2","article-title":"DNA methylation and cancer","volume":"70","author":"Kulis","year":"2010","journal-title":"Adv Genet"},{"key":"key20180107205826_b26-or-32-04-1347","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1016\/j.mam.2012.06.005","article-title":"miRNAs and cancer: an epigenetics view","volume":"34","author":"Malumbres","year":"2013","journal-title":"Mol Aspects Med"},{"key":"key20180107205826_b27-or-32-04-1347","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/1479-7364-6-23","article-title":"An emerging role for microRNAs in NF1 tumorigenesis","volume":"6","author":"Sedani","year":"2012","journal-title":"Hum Genomics"},{"key":"key20180107205826_b28-or-32-04-1347","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1002\/path.2633","article-title":"Genome-wide transcriptome analyses reveal p53 inactivation mediated loss of miR-34a expression in malignant peripheral nerve sheath tumours","volume":"220","author":"Subramanian","year":"2010","journal-title":"J Pathol"},{"key":"key20180107205826_b29-or-32-04-1347","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1186\/1471-2164-14-473","article-title":"MicroRNAome profiling in benign and malignant neurofibromatosis type 1-associated nerve sheath tumors: evidences of PTEN pathway alterations in early NF1 tumorigenesis","volume":"14","author":"Masliah-Planchon","year":"2013","journal-title":"BMC Genomics"},{"key":"key20180107205826_b30-or-32-04-1347","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1007\/s00432-012-1223-1","article-title":"MicroRNA-21 correlates with tumorigenesis in malignant peripheral nerve sheath tumor (MPNST) via programmed cell death protein 4 (PDCD4)","volume":"138","author":"Itani","year":"2012","journal-title":"J Cancer Res Clin Oncol"},{"key":"key20180107205826_b31-or-32-04-1347","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1136\/jmg.2006.045906","article-title":"Guidelines for the diagnosis and management of individuals with neurofibromatosis 1","volume":"44","author":"Ferner","year":"2007","journal-title":"J Med Genet"},{"key":"key20180107205826_b32-or-32-04-1347","doi-asserted-by":"crossref","first-page":"443","DOI":"10.3892\/ijmm.2012.1013","article-title":"Inhibition of Bcl-xL by ABT-737 enhances chemotherapy sensitivity in neurofibromatosis type 1-associated malignant peripheral nerve sheath tumor cells","volume":"30","author":"Lee","year":"2012","journal-title":"Int J Mol Med"},{"key":"key20180107205826_b33-or-32-04-1347","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1002\/wsbm.35","article-title":"Genome-wide DNA methylation profiling","volume":"2","author":"Bibikova","year":"2010","journal-title":"Wiley Interdiscip Rev Syst Biol Med"},{"key":"key20180107205826_b34-or-32-04-1347","first-page":"407","article-title":"Identification of differentially expressed genes related to NF1-associated malignant transformation from a patient with neurofibromatosis type 1","volume":"30","author":"Jeong","year":"2008","journal-title":"Genes Genomics"},{"key":"key20180107205826_b35-or-32-04-1347","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1159\/000100475","article-title":"Methylation status of genes upregulated by demethylating agent 5-aza-2\u2032-deoxycytidine in hepatocellular carcinoma","volume":"71","author":"Hirasawa","year":"2006","journal-title":"Oncology"},{"key":"key20180107205826_b36-or-32-04-1347","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1038\/modpathol.2009.29","article-title":"Transgelin as a suppressor is associated with poor prognosis in colorectal carcinoma patients","volume":"22","author":"Zhao","year":"2009","journal-title":"Mod Pathol"},{"key":"key20180107205826_b37-or-32-04-1347","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1006\/geno.1998.5381","article-title":"Paralogous sm22\u03b1 (Tagln) genes map to mouse chromosomes 1 and 9: further evidence for a paralogous relationship","volume":"51","author":"Stanier","year":"1998","journal-title":"Genomics"},{"key":"key20180107205826_b38-or-32-04-1347","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1038\/sj.onc.1207068","article-title":"Notch and Schwann cell transformation","volume":"23","author":"Li","year":"2004","journal-title":"Oncogene"},{"key":"key20180107205826_b39-or-32-04-1347","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1111\/j.1600-0463.2007.apm_636.xml.x","article-title":"Epigenetic changes in cancer","volume":"115","author":"Gr\u00f8nbaek","year":"2007","journal-title":"APMIS"},{"key":"key20180107205826_b40-or-32-04-1347","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/978-1-4419-9967-2_2","article-title":"DNA hypomethylation and hemimethylation in cancer","volume":"754","author":"Ehrlich","year":"2013","journal-title":"Adv Exp Med Biol"},{"key":"key20180107205826_b41-or-32-04-1347","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/j.molonc.2012.07.007","article-title":"DNA methylation and microRNA dysregulation in cancer","volume":"6","author":"Suzuki","year":"2012","journal-title":"Mol Oncol"},{"key":"key20180107205826_b42-or-32-04-1347","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1375\/twin.13.6.582","article-title":"Monozygotic twins with neurofibromatosis type 1 (NF1) display differences in methylation of NF1 gene promoter elements, 5\u2032 untranslated region, exon and intron 1","volume":"13","author":"Harder","year":"2010","journal-title":"Twin Res Hum Genet"},{"key":"key20180107205826_b43-or-32-04-1347","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1038\/ejhg.2009.129","article-title":"Differential MSH2 promoter methylation in blood cells of Neurofibromatosis type 1 (NF1) patients","volume":"18","author":"Titze","year":"2010","journal-title":"Eur J Hum Genet"},{"key":"key20180107205826_b44-or-32-04-1347","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.cancergencyto.2004.08.016","article-title":"Analysis of somatic NF1 promoter methylation in plexiform neurofibromas and Schwann cells","volume":"157","author":"Fishbein","year":"2005","journal-title":"Cancer Genet Cytogenet"},{"key":"key20180107205826_b45-or-32-04-1347","doi-asserted-by":"crossref","first-page":"2820","DOI":"10.1016\/j.ejca.2004.07.021","article-title":"Methylation analysis of the neurofibromatosis type 1 (NF1) promoter in peripheral nerve sheath tumours","volume":"40","author":"Harder","year":"2004","journal-title":"Eur J Cancer"},{"key":"key20180107205826_b46-or-32-04-1347","doi-asserted-by":"crossref","first-page":"e47595","DOI":"10.1371\/journal.pone.0047595","article-title":"Impaired Pten expression in human malignant peripheral nerve sheath tumours","volume":"7","author":"Bradtm\u00f6ller","year":"2012","journal-title":"PLoS One"},{"key":"key20180107205826_b47-or-32-04-1347","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1006\/geno.1998.5267","article-title":"Expression and cytogenetic localization of the human SM22 gene (TAGLN)","volume":"49","author":"Camoretti-Mercado","year":"1998","journal-title":"Genomics"},{"key":"key20180107205826_b48-or-32-04-1347","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1093\/oxfordjournals.jbchem.a021722","article-title":"Structure and expression of the human SM22\u03b1 gene, assignment of the gene to chromosome 11, and repression of the promoter activity by cytosine DNA methylation","volume":"122","author":"Yamamura","year":"1997","journal-title":"J Biochem"},{"key":"key20180107205826_b49-or-32-04-1347","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/j.biocel.2008.02.011","article-title":"Transgelin: an actin-binding protein and tumour suppressor","volume":"41","author":"Assinder","year":"2009","journal-title":"Int J Biochem Cell Biol"},{"key":"key20180107205826_b50-or-32-04-1347","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1586\/14789450.2014.860358","article-title":"Transgelins, cytoskeletal proteins implicated in different aspects of cancer development","volume":"11","author":"Dvorakova","year":"2014","journal-title":"Expert Rev Proteomics"},{"key":"key20180107205826_b51-or-32-04-1347","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1016\/j.fertnstert.2011.06.052","article-title":"TAGLN expression is deregulated in endometriosis and may be involved in cell invasion, migration, and differentiation","volume":"96","author":"Dos Santos Hidalgo","year":"2011","journal-title":"Fertil Steril"},{"key":"key20180107205826_b52-or-32-04-1347","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1111\/cas.12107","article-title":"Upregulation of transgelin is an independent factor predictive of poor prognosis in patients with advanced pancreatic cancer","volume":"104","author":"Zhou","year":"2013","journal-title":"Cancer Sci"},{"key":"key20180107205826_b53-or-32-04-1347","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/1471-2121-14-17","article-title":"Stromal fibroblasts in the microenvironment of gastric carcinomas promote tumor metastasis via upregulating TAGLN expression","volume":"14","author":"Yu","year":"2013","journal-title":"BMC Cell Biol"},{"key":"key20180107205826_b54-or-32-04-1347","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1227\/01.NEU.0000190651.45384.8B","article-title":"Molecular, genetic, and cellular pathogenesis of neurofibromas and surgical implications","volume":"58","author":"Gottfried","year":"2006","journal-title":"Neurosurgery"},{"key":"key20180107205826_b55-or-32-04-1347","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1007\/s00401-011-0928-6","article-title":"Molecular mechanisms promoting the pathogenesis of Schwann cell neoplasms","volume":"123","author":"Carroll","year":"2012","journal-title":"Acta Neuropathol"},{"key":"key20180107205826_b56-or-32-04-1347","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1038\/nrc1877","article-title":"Fibroblasts in cancer","volume":"6","author":"Kalluri","year":"2006","journal-title":"Nat Rev Cancer"},{"key":"key20180107205826_b57-or-32-04-1347","doi-asserted-by":"crossref","first-page":"9790","DOI":"10.1074\/jbc.M110086200","article-title":"Loss of transgelin in breast and colon tumors and in RIE-1 cells by Ras deregulation of gene expression through Raf-independent pathways","volume":"277","author":"Shields","year":"2002","journal-title":"J Biol Chem"},{"key":"key20180107205826_b58-or-32-04-1347","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1016\/j.fertnstert.2012.11.055","article-title":"MicroRNA miR-145 inhibits proliferation, invasiveness, and stem cell phenotype of an in vitro endometriosis model by targeting multiple cytoskeletal elements and pluripotency factors","volume":"99","author":"Adammek","year":"2013","journal-title":"Fertil Steril"},{"key":"key20180107205826_b59-or-32-04-1347","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.ijom.2007.06.012","article-title":"Diabetes enhances cell proliferation but not Bax\/Bcl-2-mediated apoptosis during oral oncogenesis","volume":"37","author":"Vairaktaris","year":"2008","journal-title":"Int J Oral Maxillofac Surg"},{"key":"key20180107205826_b60-or-32-04-1347","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1097\/CCO.0b013e3283412eb4","article-title":"DNA methylation and cancer: ghosts and angels above the genes","volume":"23","author":"Sin\u010di\u0107","year":"2011","journal-title":"Curr Opin Oncol"}],"container-title":["Oncology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/spandidos-publications.com\/10.3892\/or.2014.3379\/download","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,13]],"date-time":"2019-08-13T14:33:37Z","timestamp":1565706817000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.spandidos-publications.com\/10.3892\/or.2014.3379"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,8,4]]},"references-count":60,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2014,8,4]]},"published-print":{"date-parts":[[2014,10]]}},"alternative-id":["10.3892\/or.2014.3379"],"URL":"https:\/\/doi.org\/10.3892\/or.2014.3379","relation":{},"ISSN":["1021-335X","1791-2431"],"issn-type":[{"value":"1021-335X","type":"print"},{"value":"1791-2431","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,8,4]]}}}